Ace Investor Ashish Kacholia invests in TechInvention Lifecare Limited

▴ Ace Investor Ashish Kacholia
Renowned Ace Investor Ashish Kacholia has invested in TechInvention Lifecare Limited, a Vaccine focussed biotechnology company headquartered in Mumbai. Established in 2016, TechInvention is recognized for its innovative contributions to Global Healthcare.

Renowned Ace Investor Ashish Kacholia has invested in TechInvention Lifecare Limited, a Vaccine focussed biotechnology company headquartered in Mumbai. Established in 2016, TechInvention is recognized for its innovative contributions to Global Healthcare.

 

The investment is to primarily fund TechInvention’s upcoming state-of-the-art NexGen Vaccine Manufacturing facility in Navi Mumbai. The facility is designed to scale-up & manufacture vaccines from its robust R&D portfolio of vaccine candidates encompassing contemporary platforms such as recombinant subunit, conjugates, VLP (virus-like particles), adenoviral vector & mRNA platforms.

 

Commenting on the investment, Mr Kacholia said: “We are delighted to support TechInvention in getting life-saving, innovative vaccines commercialized & reach millions across India & beyond. The founders of TechInvention are techno-commercially savvy & together we hope to build a high-quality business over the next few years”.

 

Syed S. Ahmed, Founder & CEO of TechInvention Lifecare Limited, added: “We are delighted to have Mr. Kacholia’s confidence in our vision & his participation is an assurance of the advancement of our Manufacturing facility project titled –‘Global Collaborative Centre for Medical Counter Measures (GCMC’). His belief in our mission reinforces India’s role as a trusted enabler of equitable health solutions for low & middle-income countries (LMICs).”

 

Since inception, TechInvention has demonstrated steady growth, achieving a 65% CAGR in revenue. The company is now entering into Orbit Next, driven by its commitment to developing novel human vaccines that prevent infectious diseases & enhance global health resilience.

 

In recognition of its contribution to global health innovation & achievements, TechInvention has featured in Forbes India’s Top 200 Companies with Global Business Potential (2024), recipient of the SME Biopharma Company of the Year Award (2025), and rated as a “Lowest-Risk SME” by Dun & Bradstreet (2025).

The partnership with Mr Kacholia marks a significant milestone in TechInvention’s journey, not just as an investment, but as a strong endorsement of our vision to combine biotechnology & sustainability enabling equitable access & drive change on a global scale.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026